CNS specialist Neuraxpharm has appointed Philipp Pohoralek as the company’s new commercial central region officer and country manager for Germany from the start of September. He will focus on strengthening the company’s position in key areas, such as expanding its product portfolio in medical cannabis and in the consumer healthcare market.
With nearly ten years of experience in the pharmaceutical industry, Pohoralek joins Neuraxpharm from Viatris where he most recently served as head of finance, Germany. He represents the latest executive to move from Viatris to Neuraxpharm this year, after Magnus Wassén became general manager of Neuraxpharm Nordics Also see "Neuraxpharm Expands Into The Nordics With New Leader From Viatris" - Generics Bulletin, 8 April, 2021. and Maximilian von Wülfing was appointed to the newly-created position of chief operating officer